Mavefund EN
Cellebrite DI logo

Cellebrite DI

CLBT
Letzter Kurs (USD) US$12.10
Marktkapitalisierung (USD) US$2.8b
Kursänderung 12 Monate -26.21%
Loading the 12-month Mave Thesis and 1-month news signal

Start Heute Aktien Watchlist

Cellebrite DI Überblick

Branche: Software Infrastructure

Sektor: Technology

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation. The company's Universal Forensic Extraction Device solution addresses problems in accessing digital information, including complicated device locks, encryption barriers, deleted and unknown content, and other obstacles that can prevent critical evidence from coming to light. It also offers Seeker solution that provides the ability to analyze video footage; OSINT Analyze, a real-time deep dive solution used to analyze open-source information, such as the surface web, deep web, and the dark web; and Crypto Tracer, which analyzes blockchain transactions together with related data from an extensive list of sources to identify and categorize wallets, and transactions. The company serves federal and state and local agencies, as well as enterprise companies and service providers. It has operations in the United States, Germany, Singapore, Australia, Brazil, United Kingdom, France, Canada, Japan, and India. The company was incorporated in 1999 and is based in Petah Tikva, Israel. Cellebrite Mobile Synchronization Ltd. operates as a subsidiary of Sun Corporation. Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including chil

Research-Überblick

Letztes Berichtsdatum 2026-08-18

Diese Mavefund-Research-Seite bündelt geprüfte Informationen zu Cellebrite DI (CLBT): Unternehmensprofil, Kursverlauf, verknüpfte Primärquellen, verfügbare Finanzberichte, Research-Signale und zu prüfende Risiken.

Börsennotierung
CLBT · Nasdaq · MIC XNAS
Land
United States
Handelswährung
USD
Branche
Software Infrastructure
Finanzdaten
Jahres- und Zwischenabschlüsse verfügbar
Letzte Primärquelle
SEC EDGAR · veröffentlicht 2026-08-18
Primärquellen

Die Abdeckung wird automatisch aktualisiert und erst nach einer Datenintegritätsprüfung veröffentlicht. Nur Research-Unterstützung; keine persönliche Anlageberatung.

Mavefund ordnet die verfügbaren Fundamentaldaten, Bewertungskennzahlen und Risikofaktoren von Cellebrite DI für einen nachvollziehbaren Research-Prozess ein.

Score

Veröffentlichte Ergebnisse

Was das Unternehmen berichtet hat – mit kompakter Quellenangabe.

Veröffentlicht Aug 18, 2026

Interim result summary

Revenue was $480.8M (+21% YoY). Free cash flow margin was +34% (YoY).

Revenue $480.8M +21% YoY
Free cash flow margin +34% YoY

Was sich verändert hat

  • Revenue +21% YoY to $480.8M.
  • Free cash flow margin was +34% YoY.

Guidance / outlook

No formal outlook was extracted from this filing excerpt. Open the source document to review full management commentary.

Earnings release Bericht öffnen

Source: SEC EDGAR company-filed earnings materials. Dates and source identifiers are retained for verification; review the original filing before relying on extracted report details.

Weitere aktuelle Ergebnisunterlagen

Geprüfte Signal-Evidenz

Aktuelle Nachrichten

Unternehmensrelevante Artikel aus Quellen, die die Relevanz- und Zuverlässigkeitsprüfung des Mave Signals bestehen.

Gewinn je Aktie

Score 2.00/5
Cellebrite DI earns a low score, as its Earnings Per Share (EPS) has not shown continuous growth over the last six years. Notable counterparts in the sector with high scores includes Applied Materials Inc Alphabet Inc Class A Check Point Software Technologies Ltd
In Software Infrastructure industry , Check Point Software Technologies Ltd , Microsoft Corporation , Adobe Systems Incorporated are companies with high ratings.

Eigenkapitalrendite

Score 0.29/5
Cellebrite DI exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include Applied Materials Inc Alphabet Inc Class A Check Point Software Technologies Ltd
Cellebrite D... CLBT US$2.8b
Applied Mate... AMAT US$478.4b
Alphabet Inc... GOOGL US$4.3t
Check Point ... CHKP US$13.8b

Nettomarge

Score 1.64/5
Cellebrite DI olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include Applied Materials Inc Alphabet Inc Class A Check Point Software Technologies Ltd
Cellebrite D... CLBT US$2.8b
Applied Mate... AMAT US$478.4b
Alphabet Inc... GOOGL US$4.3t
Check Point ... CHKP US$13.8b

Aktienrückkäufe

In Software Infrastructure industry , Check Point Software Technologies Ltd , Microsoft Corporation , Adobe Systems Incorporated are companies with high ratings.

Verschuldung

Score 1.40/5
Cellebrite DI registers a lower score in the category as a result of its elevated leverage ratio over the past six years compared to the sector median value. Conversely, other companies in the same sector, including Applied Materials Inc Alphabet Inc Class A Check Point Software Technologies Ltd have achieved high scores.
Cellebrite D... CLBT US$2.8b
Applied Mate... AMAT US$478.4b
Alphabet Inc... GOOGL US$4.3t
Check Point ... CHKP US$13.8b

Finanzberichte

Vom Unternehmen veröffentlichte Berichtsdaten, strukturiert und mit der Originalquelle verknüpft.

Berichtswährung
Geprüfte, quellenverknüpfte Finanzberichte werden geladen, sobald dieser Abschnitt sichtbar wird.

Quellendetails werden mit den Berichtsdaten geladen. Die Werte sind standardisierte Unternehmensangaben zur Research-Unterstützung, keine persönliche Anlageberatung.

Finanzkennzahlen

Jährlich Quartalsweise

Finanzen
Profitabilität
Wachstum
Cashflow
Finanzielle Stabilität
Effizienzkennzahlen

Cellebrite DI logo

Cellebrite DI

US$12.10

US$11.45

-4.5% vs price

US$2.8b

5.27%

-26.21%